Investors Land BBIO 7.6% Lower Than Its Secondary Stock Offering
June 07, 2024 at 10:27 AM EDT
Looking back to 94 days ago, BridgeBio Pharma Inc (BBIO) priced a 8,620,690 share secondary stock offering at $29.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..